ArticleEvidence-based complementary and alternative medicine : eCAM2022

Exploration of Potential Targets and Mechanisms of Fisetin in the Treatment of Non-Small-Cell Lung Carcinoma via Network Pharmacology and In Vitro Validation.

Junjun Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.